LENTIVIRAL VECTORS MARKET ANALYSIS

Lentiviral Vectors Market, By Product Type (1st-generation, 2nd-generation, and 3rd-generation), By Indication (HIV, β-thalassemia, X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy, and Wiskott-Aldrich Syndrome), By End User (Hospitals, Clinics, and Research Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI4068
Pages :220
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global Lentiviral Vectors Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global lentiviral vectors market over the forecast period owing to the increase in license agreement and collaboration by market key players and increasing prevalence of HIV. For instance, on June 21 2023, according to the Centers for Disease Control and Prevention, in the U.S., an estimated 1.2 million people were living with HIV as of the end of 2021, and about 87% of them were aware that they had HIV.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa